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Objectives: Dementia affects many people, with numbers expected to grow as populations age. Many people with dementia
receive informal/family/unpaid care, for example, from a spouse or child, which may affect carer quality of life. Measuring the
effectiveness of health/social care interventions for carers requires a value measure of the quality-of-life impact of caring. This
motivated development of the Scales Measuring the Impact of Dementia on Carers-D (SIDECAR-D) instrument. This study
aimed to obtain general population values for SIDECAR-D to aid incorporating the impact of caring in economic evaluation.
Methods: Members of the UK general public completed a best–worst scaling object case survey, which included the 18
SIDECAR-D items and EQ-5D-3L descriptions. Responses were analyzed using scale-adjusted finite mixture models.
Relative importance scores (RISs) for the 18 SIDECAR-D items formed the SIDECAR-D relative scale measuring the relative
impact of caring. The SIDECAR-D tariff, on the full health = 1, dead = 0 scale, was derived by rescaling EQ-5D-3L and
SIDECAR-D RISs so the EQ-5D-3L RISs equaled anchored valuations of the EQ-5D-3L pits state from a visual analog scale task.
Results: Five hundred ten respondents completed the survey. The model had 2 parameter and 3 scale classes. Additive utility
decrements of SIDECAR-D items ranged from –0.05 to –0.162. Utility scores range from 0.95 for someone affirming 1 item to
–0.297 for someone affirming all 18.
Conclusion: SIDECAR-D is a needs-based scale of the impact on quality of life of caring for someone with dementia, with a
valuation tariff to support its use in economic evaluation.
Keywords: carers, dementia, quality of life, valuation, best-worst scaling, visual analog scale.
VALUE HEALTH. 2020; -(-):-–-Introduction
Dementia is a syndrome linked to a range of progressive brain
diseases causing gradual decline in mental abilities and increasing
functional difficulties. People with dementia often have care
provided by family or friends. Being a caregiver can place a large
burden on people in time and resources, disruption to daily life,
and psychological effects.1
Dementia mainly affects those aged over 65, and increased life
expectancy means that globally the number of people diagnosed is
expected to rise from 47 million in 2015 to 3 times that by 2050.2
As the number of people with dementia increases, so too does the
societal burden, meaning greater need for support and services
targeting people with dementia and their carers.ss correspondence to: Edward J. D. Webb, PhD, Leeds Institute of Health Scie
.uk
15 - see front matter Copyright ª 2020, ISPOR–The Professional Society for
cess article under the CC BY license (http://creativecommons.org/licenses/b
doi.org/10.1016/j.jval.2020.04.1827By carer we refer to any person providing care for someone
with dementia who is not formally employed to do so. This defi-
nition encompasses the terms informal carer, family carer, and
unpaid carer used elsewhere.
Efficient and optimal allocation of resources in this area re-
quires preference-based quality-of-life measures, for both people
with dementia and their carers. The relationship between severity
of dementia and impact on a carer’s quality of life is nonlinear. For
example, a worsening of the condition may lead to greater pro-
vision of formal support, or the person moving into a nursing
home, reducing carer burden. Carers may also adjust to their
caring role over time, meaning their quality of life improves as
severity of dementia increases.3 Thus, extrapolating the impact on
carers from knowledge about people with dementia is impossible:
carers’ quality of life must be measured directly.nces, Worsley Building, Clarendon Way, Leeds, LS2 9NL, UK. Email: e.j.d.webb@
Health Economics and Outcomes Research. Published by Elsevier Inc. This is an
y/4.0/).
2 VALUE IN HEALTH - 2020Assigning values to the impact of caring allows the comparison
of different individuals, different points for individuals, and the
effectiveness of carer-targeted interventions. In addition, in-
terventions targeted at people with dementia themselves may
improve quality of life for their carers, termed spillovers. Recent
National Institute for Health and Care Excellence and US panel
guidance4,5 on cost-effectiveness highlights the need to develop
methods for valuing spillovers to formally consider them within
economic evaluation, to determine the true overall benefit of in-
terventions, and make decisions that maximize benefits from
scarce healthcare resources.6
In many health systems, including the UK National Health
Service,7 the preferred measure of health benefit is quality-
adjusted life-years (QALYs), a composite endpoint comprising
both quality and length of life. Quality is captured in utility or
preferences for health states where 1 is defined as full health, 0 is
defined as equivalent to dead, and negative values represent
health considered worse than dead. Thus, 1 QALY is the equivalent
of living 1 year in full health.
Because caring for someone with dementia can have an impact
on all aspects of an individual’s life, generic health measures such
as EQ-5D may detect certain aspects of health-related caring
impact, for example, preventing people from performing their
usual activities. Health-related quality-of-life measures have been
used with family carers in economic evaluations, including in
dementia.8 Nevertheless, there is concern they capture only
limited aspects of the impact of caring on quality of life.9,10 Mea-
sures including care-related items, such as relationships, fulfill-
ment, and support, might be more appropriate for capturing carer
quality of life. Many such general measures exist,11,12 but few have
preference-based scoring algorithms for use in economic
evaluation.
The Adult Carers Quality of Life questionnaire13 has been suc-
cessfully employed in assessing carer services,14 including for
carers of people with dementia.15 Nevertheless, Adult Carers
Quality of Life questionnaire items have not been valued, meaning
the relative impact of each cannot be assessed. The CarerQoL16 and
Carer Experience Scale (CES)17 have been valued using choice-
based methods. Nevertheless, the outcome scores cannot be
obviously compared to, or summed with, patient QALYs, because
they are not on the full health = 1, dead = 0 scale. The Dementia
Quality of Life Scale for Older Family Carers18 is specific to de-
mentia carers, but only a subset (older family members). This
neglects many younger carers, for example, those caring for a
parent, for a spouse with young-onset dementia, or for friends.
Valuation is also not available for the Dementia Quality of Life
Scale for Older Family Carers.
There is hence a need for a scale assessing the impact on quality
of life of caring for someone with dementia that reflects their ex-
periences, summarizes the relative severity of the quality-of-life
impact, and generates QALY values for economic assessment. The
DEmentia Carers Instrument DEvelopment project created the
SIDECAR (Scales measuring the Impact of DEmentia on CARers)
instrument. SIDECAR was developed using a needs-led approach,
with items generated from carers only, using exact phrases where
possible. Development and evaluation followed Consensus-Based
Standards for the Selection of Health Measurement Instruments,19
including interviews (N = 42),20,21 to generate an item pool and
psychometric evaluation of the initial itempool.22 This resulted in 3
instruments, SIDECAR-D (18 items), which measures the direct
impact of caring for someonewith dementia; SIDECAR-I (10 items),
which measures the indirect effect; and SIDECAR-S (11 items),
which measures support and informational needs.22
This article details a valuation study of SIDECAR-D. Two mea-
sures are presented, the SIDECAR-D relative scale (SIDECAR-D-RS),which measures the relative impact of caring for someone with
dementia on a 0 to 100 scale, and the SIDECAR-D tariff, which
gives the impact on a scale with full health = 1 and dead = 0. The
SIDECAR-D-RS is an easy-to-understand relative scale that can be
used to compare groups of carers or one group over time. The
SIDECAR-D tariff, being anchored to the scale usually used in
analyzing health and care interventions, may be used to compare
carer interventions with interventions in other fields, and to
evaluate carer spillovers. Different ranges for the measures were
deliberately chosen to emphasize that they are on different scales.Methods
Survey Development
SIDECAR-D items are scored using a binary agree/disagree
response format. The time frame reference is “today.” Examples
are “I don’t take very good care of myself” and “I often feel I want
to escape my caring responsibilities.” The full list of items is not
publicly available, although SIDECAR is free for use in public
health, social care, voluntary sector, and not-for-profit organiza-
tions following registration (to use SIDECAR, please register with
the University of Leeds Fast Licensing Platform at www.licensing.
leeds.ac.uk).
The valuation exercise used best-worst scaling object case
(BWS-OC) (also known as BWS case 1). It elicits relative preference
for many items by presenting a small subset, using the simple task
of survey participants choosing which item is best (or alternative
term depending on context) and which is worst. Although the
related method of BWS profile case has been used for valua-
tion17,23 and some BWS-OC studies in healthcare exist,24 we are
not aware of a study using BWS-OC to value a survey instrument.
Studies valuing items on a full health = 1, dead = 0 scale often
use time-trade off (TTO)25 or standard gamble (SG).26 Best–worst
scaling object case was carefully chosen to suit SIDECAR-D. In TTO
and SG, survey participants are shown health states or vignettes
constructed from the items being valued. In the former, they
identify the length of life in full health that they consider equiv-
alent to 10 years in the state being valued. In the latter, they state
the highest probability of instant death they would risk to live 10
years in full health rather than live 10 years in the state being
valued.
Both methods were unsuitable here. Completing SIDECAR-D
entails asking individuals to agree or disagree with a list of
statements, making it difficult to create descriptions of states
without using negations of the statements that do not form part of
the instrument. It would be possible to create vignettes by listing
the statements agreed with, but there are 18 items, some
comprising lengthy sentences originating in voices of carers
themselves, reflecting the realities and nuances of their experi-
ences. Thus vignettes for severe SIDECAR-D states would be overly
long and difficult for respondents to take in. In addition, the trade-
off between quality and length of life is not as intuitive for carers
as it is for patients, because their own condition is not being
valued. Caring for someone means that to some extent someone is
dependent on them, which may also influence their willingness to
trade the possibility of death. Finally, there are 218 = 262 144
SIDECAR-D states, making valuing any meaningful subset of them
using TTO or SG impractical.
Another alternative is discrete choice experiments (DCEs),27 in
which individuals choose which of 2 options they prefer. Discrete
choice experiments can value a large number of states, and there
is some evidence that they are more reliable than BWS profile
case.28 Although they could in theory be employed here, choosing
-- 3between 2 potentially lengthy SIDECAR-D vignettes would present
an impractical burden for survey participants.
The five EQ-5D level 3 descriptions were added to the 18
SIDECAR-D items and a statistical design constructed using the
crossdes package for R. A design was created that balanced in
order of priority (1) items, (2) pairs of items, and (3) items in a
given position appearing an equal amount of times. The design
had 6 versions, each with 8 questions. Participants were shown 6
items and indicated which would have the most negative and
least negative impact on their quality of life. For an example, see
the survey instrument which is included as Supplemental
Materials found at https://doi.org/10.1016/j.jval.2020.04.1827.
Participants also completed 2 visual analog scale (VAS) tasks,
rating health states on a scale from 100 (the best health you can
imagine) to 0 (the worst health you can imagine). A screenshot is
included in the survey instrument provided as Supplemental
Materials found at https://doi.org/10.1016/j.jval.2020.04.1827.
Participants rated their own health today, then rated 11111, 33333,
and dead. From this task a valuation of 33333 on the full health = 1,
dead = 0 scale was obtained and used to anchor valuations. Finally,
participants answered questions about themselves (age, sex, etc.)
to assess the sample’s representativeness. For details, see the
survey instrument provided as Supplemental Materials found at
https://doi.org/10.1016/j.jval.2020.04.1827.
The surveywas testedwith 10 carers, including carers for people
with dementia andwordingof questions and instructions refined in
response to feedback. The surveywas administered online, through
a survey company, and collected a representative UK general public
sample from an existing panel. The survey was piloted with 50 re-
spondents. Responseswere gathered betweenAugust 22, 2018, and
September 2, 2018, with a recruitment target of 500 (including 50
from the pilot, because no further changes were made). Formal
power calculations were not performed; however, the sample size
was considered more than adequate to estimate robust statistical
models based on past experience and previous literature.24
Analysis
The decision utility to a participant of selecting item i as having
the most negative impact on quality of life is modeled as being
ui ¼ Vi 1 εi where
Vi ¼
X23
a¼1
baxia
with baa vector of coefficients, xiaa vector of dummy variables
indicating whether item i contains attribute a, and εi an inde-
pendent and identically distributed error term following a Gumbel
distribution. The decision utility of selecting item j as the least
negative impact is uj ¼ 2 ðVj 1 εjÞ. Note that decision utilities are
on a different scale than quality-of-life utility because it is
convenient to model individuals receiving positive decision utility
payoffs for identifying the most negative quality-of-life impact. It
is assumed that individuals first select the item having the most
negative impact, then the item having the least negative impact.
The probability of a given choice is then
Pði most negative; j least negativeÞ¼

esViP
kesVk

e2sVjP
ksie2sVk

:
Where s $ 0 is the response scale indicating how much responses
are explained by the deterministic part of the model and how
much by the random part.29
Coefficients were transformed to relative importance scores
(RISs) using Orme’s method.30 Following Zhang et al,31 the linkbetween the relative importance, Ia, of an attribute in BWS-OC and
level coefficients is modeled as
aIa ¼

bmaxa 2b
min
a

where bmaxa and b
min
a are respectively the largest and smallest
coefficients associated with attribute a. Here, bmaxa is the level 1
EQ-5D coefficient, by definition 0, and bmina the level 3 utility
decrement on a given EQ-5D dimension. Summing across all EQ-
5D dimensions:
X5
a¼1
IEQ25Da ¼
X5
a¼1
blevel 3a
VAS valuations of state 33333 on the full health = 1, dead = 0 scale
are found from
VAS0 2 133333 ¼
VAS333332VASdead
VAS111112VASdead
:
By equating
P5
a¼1b
level 3
a and VAS
0 2 1
33333 , RIS from the BWS-OC are
anchored to the full health = 1, dead = 0 scale by multiplying by
a ¼ 12 VAS
021
33333P5
a¼1I
EQ25D
a
:
The anchoring approach described above requires individuals to give
logically consistent VAS responses, that is, VAS11111,VAS33333 and
VAS11111,VASdead (though it does not preclude VASdead,VAS33333,
that is, 33333 consideredworse than dead). Thus respondents giving
illogical responses were excluded from analysis.
Scale-adjusted finite mixture models32 were estimated, which
allow for nP classes of response parameters and nS scale param-
eters, with the first normalized to 1. The probability of belonging
to a given parameter (scale) class p (s) is eqp=
PnP
i¼1e
qi ðefs =PnSi¼1efi Þ
with the qs and fs parameters to estimate and q1 ¼ f1 ¼ 0.
Sixteen models were estimated with between 1 and 4 prefer-
ence and between 1 and 4 scale classes. The final preferred model
was the one minimizing the Bayesian Information Criterion.
The SIDECAR-D tariff, anchored to the full health = 1, dead =
0 scale, is calculated by taking the mean anchored valuations for
each parameter and scale class weighted by probability of class
membership. Similarly, the SIDECAR-D relative scale, giving the
relative impact on an individual on a 0 to 100 scale, is found by
taking a weighted mean over classes of RIS regarding only
SIDECAR-D items. Note that SIDECAR-D-RS and the SIDECAR-D
tariff have different endpoints as well as moving in opposite di-
rections: a high relative scale score implies a large quality-of-life
impact, whereas a high tariff value implies a low impact.
Statistical significance was judged at the 5% level after
adjustment using Holm’s sequential Bonferroni correction.33
Design and analysis was conducted using R version 3.3.1, with
models estimated using the Choice Modelling Centre Code for R
version 1.1.34Results
Five hundred ten respondents completed the survey, of which
38 (7.45%) were excluded for illogical VAS responses, leaving 472
for analysis.
Table 1 summarizes respondent demographics. Women are
overrepresented both in the full (58.6%) and analysis (59.7%)
sample compared to the UK population (50.6%),35 with more men
excluded for illogical VAS responses. The full and analysis samples
Table 1. Respondent demographics and summary of VAS
responses.
All
respondents
Illogical
VAS
Analysis
sample
Sex (%)
Female 58.6 44.7 59.7
Male 41 52.6 40
Other/prefer not to
say
0.392 2.63 0.212
Age
Mean 48.4 45.2 48.7
SD (14.7) (14) (14.7)
Education (%)
Left school after min
age
76.9 68.4 77.5
Degree 56.7 63.2 56.1
Occupation (%)
(Self-)employed 58.8 71.1 57.8
Retired 20.4 13.2 21
Housework 8.63 2.63 9.11
Student 2.16 5.26 1.91
Unemployed 3.92 2.63 4.03
Other 6.08 5.26 6.14
Self-report 11111 (%) 44.5 39.5 44.9
VAS 11111
Mean 88.4 51.4 91.4
SD (19.3) (32.3) (14.2)
VAS 33333
Mean 20.3 51.5 17.8
SD (20.3) (32.6) (16.6)
VAS dead
Mean 11.4 62.2 7.34
SD (22.2) (37.8) (14)
VAS own health
Mean 73.7 66.3 74.3
SD (19.4) (21.1) (19.1)
VAS 33333 (anchored)
Mean - - 0.0278
SD - - (1.06)
N 510 38 472
SD indicates standard deviation; VAS, visual analog scale.
Table 2. Best-worst scaling responses summary.
Attribute Times
presented
Most
negative
Least
negative
Difference
EQ-5D pain/
discomfort L3
1023 526 33 493
EQ-5D mobility L3 1020 444 46 398
EQ-5D anxiety/
depression L3
1009 355 46 309
EQ-5D self-care L3 956 276 40 236
SIDECAR-A item 5 961 260 109 151
EQ-5D usual
activities L3
1010 187 106 81
SIDECAR-A item 14 945 159 79 80
SIDECAR-A item 1 1028 168 97 71
SIDECAR-A item 12 958 143 113 30
SIDECAR-A item 4 1027 144 119 25
SIDECAR-A item 13 934 112 117 25
SIDECAR-A item 6 1013 128 149 221
SIDECAR-A item 7 941 122 199 277
SIDECAR-A item 3 1028 106 235 2129
SIDECAR-A item 10 1007 89 218 2129
SIDECAR-A item 18 953 52 186 2134
SIDECAR-A item 8 943 62 196 2134
SIDECAR-A item 11 937 53 194 2141
SIDECAR-A item 2 1015 88 239 2151
SIDECAR-A item 9 948 81 275 2194
SIDECAR-A item 16 1016 66 276 2210
SIDECAR-A item 15 954 61 330 2269
SIDECAR-A item 17 1030 94 374 2280
SIDECAR-A indicates Scales Measuring the Impact of Dementia on Carers-A.
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generally reported good health, with 44.9% of the analysis sample
reporting being in state 11111. The proportion is somewhat lower
(39.5%) for respondents who gave illogical VAS responses, but the
full sample is similar (44.5%) to the analysis sample.
Mean VAS ratings in the analysis sample are plausible, with 91.4
for 11111, 17.8 for 33333, and 7.34 for dead, and a mean anchored
valuation of 33333 of 0.03. Respondents giving illogical VAS re-
sponses have less plausible ratings, with 51.4, 51.5, and 62.2,
respectively.
Table 2 summarizes the analysis sample’s BWS-OC choices.
Five of the top 6 differences in the most negative and the least
negative responses are for EQ-5D items. These were chosen as
having the most negative impact on quality of life far more often
than they were chosen as having the least negative impact. At the
other end of the scale, several items were chosen as having the
least negative impact far more often than the most negative
impact. This variation is an indication participants understood the
tasks and could make meaningful distinctions between the
impacts of different items.Table 3 gives models’ Bayesian Information Criterion. The
optimal fit had 2 preference and 3 scale classes. Table 4 gives the
model coefficients. The second scale class has the largest scale
parameter, that is, lowest error variance (14.6), followedby the third
(7.61), then the first (normalized to 1). Respondents were most
likely to belong to the second class (probability = 0.44), then thefirst
(probability = 0.31), then the third (probability = 0.25). There are
differences between the 2 parameter classes. In particular, in class 2
the EQ-5D items have the 5 largest coefficients, whereas in class 1,
there is a SIDECAR-D item in the top 5, and usual activities has only
the tenth highest coefficient. Respondents were most likely to
belong to parameter class 2 (probability = 0.59).
Table 5 shows the SIDECAR-D relative scale and tariff, with
Figure 1 showing utility decrements for SIDECAR-D items and EQ-
5D level 3 descriptions. The largest utility decrement for an item is
–0.162 on the SIDECAR-D tariff, equivalent to 15.2 on the SIDECAR-
D-RS. All other items lower utility by 0.1 or less on the SIDECAR-D
tariff. Scores on the SIDECAR-D tariff range from 0.95 if affirming
only item 17 to –0.297 if affirming all 18 items.
Discussion
This study successfully assigned values to SIDECAR-D items.
Values of some items on the full health = 1, dead = 0 scale are
considerable. For example, item 5, “I dread the future,” has a value
Table 3. Bayesian information criterion for scale-adjusted finite mixture models.
1 scale class 2 scale classes 3 scale classes 4 scale classes
1 parameter class 22930.45 22022.22 21983.44 21999.91
2 parameter classes 22150.9 21921.31 21910.66* 21926.69
3 parameter classes 22348.57 21961.02 21992.62 22046.5
4 parameter classes 22176.33 22183.62 22100.93 22037.96
*Lowest value.
-- 5of -0.162, a greater impact than EQ-5D-3L level 3 descriptions for
self-care and usual activities. Even SIDECAR-D items of lower
magnitude are comparable to level 2 coefficients from the EQ-5D
five-level value set for England.36 Previous exercises valuing CES
and the ICEpop CAPability measure (ICECAP), both aimed at a
population with some overlap with this one, also found large
utility decrements.17,23,37 Nevertheless, CES/ICECAP define the
lowest state in the descriptive system as 0, thus values are not
comparable, and as decrements must sum to -1, large decrements
are found by construction.Table 4. Estimated parameters from final scale-adjusted finite mixt
Attribute Parameter class 1
SIDECAR-A item 1 0.0194
SIDECAR-A item 2 20.0513
SIDECAR-A item 3 20.0108
SIDECAR-A item 4 20.0021
SIDECAR-A item 5 0.189
SIDECAR-A item 6 20.0669
SIDECAR-A item 7 20.0515
SIDECAR-A item 8 20.0572
SIDECAR-A item 9 20.0908
SIDECAR-A item 10 20.0746
SIDECAR-A item 11 20.0543
SIDECAR-A item 12 0.0395
SIDECAR-A item 13 0.011
SIDECAR-A item 14 0.0727
SIDECAR-A item 15 20.0915
SIDECAR-A item 16 20.084
SIDECAR-A item 17 20.171
SIDECAR-A item 18 20.0801
EQ-5D mobility L3 0.132
EQ-5D self-care L3 0.0742
EQ-5D usual activities L3 0.0067
EQ-5D pain/discomfort L3 0.174
EQ-5D anxiety/depression L3 0.167
qc 0
Response scale
Scale class 1 1
Scale class 2 14.6
Scale class 3 7.61
SE indicates standard error; SIDECAR A, Scales Measuring the Impact of Dementia onThis highlights that the UK general population recognize that
caring for someone with dementia can have a large impact on the
carer’s life. Items generated from the voices of carers resonate
with and are understood by the general public, reaffirming the
value of a bottom-up, carer-led process in developing a measure.
Comparing the conceptual nature of BWS-OC to alternatives,
TTO may be thought of as giving a valuation for a particular state,
whereas DCE responses can be analyzed to provide a valuation of a
descriptive system, both from the perspective of an average
member of the population. BWS-OC responses when analyzedure model.
SE Parameter class 2 SE
(0.115) 0.113 (0.0521)
(0.112) 20.218 (0.0576)
(0.0630) 20.304 (0.0586)
(0.131) 20.0006 (0.00900)
(0.142) 20.0197 (0.0575)
(0.140) 0.0215 (0.0619)
(0.131) 20.144 (0.0565)
(0.122) 20.199 (0.0543)
(0.106) 20.295 (0.0623)
(0.115) 20.217 (0.0478)
(0.119) 20.206 (0.0545)
(0.121) 0.0479 (0.0571)
(0.126) 20.0779 (0.0477)
(0.122) 0.0769 (0.0517)
(0.117) 20.415 (0.0725)
(0.119) 20.275 (0.0597)
(0.150) 20.306 (0.0620)
(0.115) 20.162 (0.0521)
(0.140) 0.682 (0.112)
(0.122) 0.476 (0.0872)
(0.122) 0.264 (0.0636)
(0.170) 0.748 (0.119)
(0.160) 0.41 (0.0810)
– 0.354 (0.238)
SE fs SE
– 0 –
(2.79) 0.372 (0.322)
(1.57) 20.194 (0.366)
Carers-A.
Table 5. SIDECAR-A tariff and SIDECAR-A-RS.
SIDECAR-A tariff SIDECAR-A-RS
SIDECAR-A item1 20.087 9.44
SIDECAR-A item2 20.061 3.71
SIDECAR-A item3 20.064 3.77
SIDECAR-A item4 20.076 6.55
SIDECAR-A item5 20.162 15.2
SIDECAR-A item6 20.069 6.34
SIDECAR-A item7 20.063 4.18
SIDECAR-A item8 20.060 3.76
SIDECAR-A item9 20.055 3
SIDECAR-A item10 20.058 3.51
SIDECAR-A item11 20.061 3.76
SIDECAR-A item12 20.088 8.58
SIDECAR-A item13 20.074 5.72
SIDECAR-A item14 20.100 10.1
SIDECAR-A item15 20.053 2.62
SIDECAR-A item16 20.056 3.11
SIDECAR-A item17 20.050 2.64
SIDECAR-A item18 20.060 3.99
Example calculation: Respondent affirms items 2, 4, 11, and 16
SIDECAR-A tariff score: 1 – 0.061 – 0.076
– 0.061 – 0.056 = 0.746
SIDECAR-A-RS score: 3.71 1 6.55 1 3.76
1 3.11 = 17.13
SIDECAR-A indicates Scales Measuring the Impact of Dementia on Carers-A;
SIDECAR-A
RS, Scales Measuring the Impact of Dementia on Carers Relative Scale.
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average population perspective.
Comparing what these values mean, BWS-OC is sometimes
used solely as a user-friendly alternative to ranking items, or as a
replacement for a VAS/rating scale.38 Nevertheless, it is possible to
extract much more information from responses, because BWS-OC
can be grounded in random utility theory,39 in the same way as
DCEs. Conceptually, this means participants’ responses to BWS-OC
tasks reflect the same underlying utility scale as DCE, TTO, and SG
tasks. Empirical evidence supports BWS-OC tasks measuring the
same utilities as DCEs (up to a scale transformation).31,40 Values
from BWS-OC are thus a utility-based measure, satisfying the
National Institute for Health and Care Excellence’s requirements
for measures suitable for use in health technology assessment.4
This study compares the specific impact on carers, represented
by SIDECAR-D, and general health impacts, represented by the
EQ-5D. The conceptual validity of doing so rests on both reflecting
the same underlying latent utility scale. SIDECAR-D hence con-
trasts with, for example, ICECAP, which seeks to measure capa-
bility.41 Previous studies have illustrated the feasibility of relating
condition-specific measures and the EQ-5D. An example is exer-
cises mapping the cancer-specific measures European Organisa-
tion for Research and Treatment of Cancer (EORTC) and
Functional Assessment of Cancer Therapy-General (FACT-G) to the
EQ-5D.42–44 Another example is bolt-ons to EQ-5D, which add
another, condition specific, dimension, for example, vision.45 In
exercises valuing bolt-ons, survey participants are presented with
combinations of EQ-5D and specific items, analogous to the ex-
ercise presented here.Quality-adjusted life-years calculated using the SIDECAR-D
tariff are potentially very different from those generated from
health-related instruments such as the EQ-5D, yet both are on the
same scale. Thus, in principle at least, interventions targeted at
carers for people with dementia or spillovers from interventions
for people with dementia may be directly and meaningfully
compared to health-focused interventions. This is potentially of
great benefit, especially given recognition of the importance of
addressing the needs of a household or family to sustain caring for
people with dementia in the community. There are also move-
ments toward greater integration of health and social care,46,47
implying a greater need to compare disparate interventions to
optimally allocate resources. It is hoped measures such as
SIDECAR-D can aid such comparisons.
There were several limitations to this study. Some SIDECAR-D
items may capture some of the essence of EQ-5D descriptions
using more vivid language. For example, item 15, “caring prevents
me from fulfilling my other activities,” sounds much like the EQ-
5D description “I am unable to perform my usual activities.”
Although being “prevented” from doing something is not the same
as being “unable” to do something, it is not clear that all partici-
pants made that distinction. Thus using SIDECAR-D in combina-
tion with EQ-5D could result in double-counting of quality of life.
Nevertheless, double-counting remains a complex issue and de-
pends on how a decision maker chooses to integrate the measures.
In addition, SIDECAR-D items were each effectively valued in
isolation. Hence, it may be that if a combination of several items
were valued as a profile that valuations would differ.
The respondent sample is reasonably representative of the UK
population, and there is no evidence that removing some re-
sponses from the analysis systematically excludes any particular
section of society. Nevertheless, certain groups, in particular
ethnic minorities, are not present in large numbers, and thus re-
sults may not accurately reflect their views.
A concern about using a general population sample might be
that they were more familiar with EQ-5D items valuing general
health than with carer-specific SIDECAR-D items. It is true that
non-carers may value SIDECAR-D items differently than carers
who have experienced them. Nevertheless, this is a well-known
phenomenon, and is not limited to this instrument.48 In addi-
tion, very few respondents will have had personal experience of
the EQ-5D level 3 descriptions. SIDECAR-D items are written in
plain language, and reflect the words of ordinary carers. Thus they
should be clear even to those without direct experience of caring,
lowering the probability that general population respondents
neglected them owing to unfamiliarity. The data bear this out:
SIDECAR-D items were ascribed meaningful utility decrements.
There is much potential for future research building on this
study. The 2 SIDECAR-D scoring systems (relative scale and tariff)
could be used to evaluate services and interventions targeted at
carers for people with dementia. Another potential use is evalu-
ating services and interventions targeted at people with dementia
themselves. For example, enabling people with dementia to be
more independent can impact the burden of caring, thus
improving carer quality of life. Existing tools and methods can
struggle to capture such spillovers,8 thus SIDECAR-D may be a
useful instrument to measure the wider impact of interventions.
The usefulness of SIDECAR-D in evaluation is an empirical
question requiring further research. It will be important in the
future to examine the validity of SIDECAR-D for ability to
discriminate between groups of carers with established differ-
ences in quality of life. Other issues are how SIDECAR-D performs
in practice in feasibility and whether interventions are capable of
changing carer responses. It should also be investigated whether
SIDECAR-D captures quality of life sufficiently alone, or whether
Figure 1. Utility decrements for Scales Measuring the Impact of Dementia on Carers-A (SIDECAR-A) items and EQ-5D-3L descriptions.
Error bars show 95% confidence intervals.
-- 7specific health-related instruments (eg, EQ-5D) should be
administered as well. Finally, future work should address to what
extent SIDECAR-D captures spillovers, and to what extent the in-
terventions that it is used to evaluate tend to be cost-effective.
Future research could address the validity of using SIDECAR to
evaluate services/interventions for non-dementia carers, although
SIDECAR was designed for carers for people with dementia, and at
present is intended for use in this population only. The partici-
pants whose voices were used in the development of the measure
were carers for people with dementia, and thus their concerns and
priorities may not be the same as for other carers. Nevertheless,
only 1 item refers specifically to dementia (“almost all of my
conversations are about dementia or caring”), meaning it would
be simple to adapt for other carer populations.
Finally, this study only assigns values to SIDECAR-D, and the
development of SIDECAR demonstrated that the indirect impact of
caring, and support and informational needs are captured by
SIDECAR-I and SIDECAR-S. Future studies could value the other 2
instruments to help capture the full burden of caring for someone
with dementia.Conclusion
This study presents an exercise valuing an instrument assess-
ing the impact on quality of life of people who care for someonewith dementia. Two scoring systems are the result, the SIDECAR-D
relative scale measuring the relative impact on a scale from 0 to
100, and the SIDECAR-D tariff, measuring the impact on a scale
with full health = 1 and dead = 0.
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